Clinical proteomics identifies potential biomarkers in Helicobacter pylori for gastrointestinal diseases

doi:10.3748/wjg.v20.i6.1529

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 6

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9768)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

584

WORD

380

HTML

6268

Figures (1-4)

341

Tables (1-1)

189

Sum=7762

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1082

Download

924

Sum=2006

Feb 14, 2014 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Feb 14, 2014; 20(6): 1529-1536
Published online Feb 14, 2014. doi: 10.3748/wjg.v20.i6.1529

Full Size Figure Download Figure

Figure 2 Flow chart of clinical proteomics platform designed for discovery and validation of Helicobacter pylori biomarkers for the diagnosis of gastrointestinal diseases. We have set up a proteomics-based platform[32] to systematically identify and validate potential biomarkers in Helicobacter pylori (H. pylori) for gastrointestinal diseases, which can provide a major methodological support for translational medicine encompassing basic biomedical research and clinical therapeutic medicine. ELISA: Enzyme-linked immunosorbent assay.

Citation: Huang CH, Chiou SH. Clinical proteomics identifies potential biomarkers in Helicobacter pylori for gastrointestinal diseases. World J Gastroenterol 2014; 20(6): 1529-1536
URL: https://www.wjgnet.com/1007-9327/full/v20/i6/1529.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i6.1529